{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:21:47Z","timestamp":1794255707959,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009282","name":"United Mitochondrial Disease Foundation","doi-asserted-by":"publisher","award":["2026 Summer Gateway to Mitochondrial Medicine Grant"],"award-info":[{"award-number":["2026 Summer Gateway to Mitochondrial Medicine Grant"]}],"id":[{"id":"10.13039\/100009282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 institutional training grant"],"award-info":[{"award-number":["T32 institutional training grant"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymgme.2026.110278","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:03:54Z","timestamp":1790435034000},"page":"110278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review"],"prefix":"10.1016","volume":"149","author":[{"given":"Dan R.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Gordon-Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elsharkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Kruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Hesselgesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Emrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen S.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2026.110278_bb0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110278_bb0010","first-page":"1380","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110278_bb0015","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949799","article-title":"Mitochondrial DNA in inflammation and immunity","volume":"21","author":"Riley","year":"2020","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110278_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri2975","article-title":"Mitochondria in innate immune responses","volume":"11","author":"West","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110278_bb0025","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110278_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110278_bb0035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.hoc.2015.06.010","article-title":"Macrophage activation syndrome","volume":"29","author":"Ravelli","year":"2015","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ymgme.2026.110278_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"16","key":"10.1016\/j.ymgme.2026.110278_bb0045","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ymgme.2026.110278_bb0050","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.ymgme.2026.110278_bb0055","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.42636","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"75","author":"Shakoory","year":"2023","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110278_bb0060","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41423-023-01086-x","article-title":"Mitochondrial DNA-triggered innate immune response: mechanisms and diseases","volume":"20","author":"Hu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.ymgme.2026.110278_bb0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"22","key":"10.1016\/j.ymgme.2026.110278_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7548","article-title":"Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice","volume":"7","author":"Lei","year":"2021","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110278_bb0075","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.4049\/jimmunol.2001016","article-title":"Loss of mitochondrial protease CLPP activates type I IFN responses through the mitochondrial DNA-cGAS-STING signaling axis","volume":"206","author":"Torres-Odio","year":"2021","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110278_bb0080","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1038\/s41467-025-59907-8","article-title":"Caspase-11 drives macrophage hyperinflammation in models of Polg-related mitochondrial disease","volume":"16","author":"VanPortfliet","year":"2025","journal-title":"Nat. Commun."},{"issue":"7548","key":"10.1016\/j.ymgme.2026.110278_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"issue":"7717","key":"10.1016\/j.ymgme.2026.110278_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ymgme.2026.110278_bb0095","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110278_bb0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.ymgme.2026.110278_bb0105","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110278_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.ymgme.2026.110278_bb0115","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.it.2019.10.008","article-title":"Emerging role of mitochondrial DNA as a major driver of inflammation and disease progression","volume":"40","author":"Zhong","year":"2019","journal-title":"Trends Immunol."},{"issue":"7329","key":"10.1016\/j.ymgme.2026.110278_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"7285","key":"10.1016\/j.ymgme.2026.110278_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"7717","key":"10.1016\/j.ymgme.2026.110278_bb0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41586-018-0363-0","article-title":"Mitochondrial double-stranded RNA triggers antiviral signalling in humans","volume":"560","author":"Dhir","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110278_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymgme.2026.110278_bb0140","first-page":"3932646","article-title":"Mitochondrial disease as a cause of neonatal hemophagocytic lymphohistiocytosis","volume":"2016","author":"Fuwa","year":"2016","journal-title":"Case Rep Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110278_bb0145","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110278_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110278_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-023-04180-w","article-title":"Inflammatory and interferon gene expression signatures in patients with mitochondrial disease","volume":"21","author":"Warren","year":"2023","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110278_bb0160","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/ana.27081","article-title":"Interferon stimulated gene expression is a biomarker for primary mitochondrial disease","volume":"96","author":"Keshavan","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2026.110278_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.100981","article-title":"Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity","volume":"37","author":"Jestin","year":"2020","journal-title":"Mol Metab."},{"issue":"4\u20135","key":"10.1016\/j.ymgme.2026.110278_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0887-2333(01)00019-4","article-title":"Mitochondrial permeability transition induced by the anticancer drug etoposide","volume":"15","author":"Cust\u00f3dio","year":"2001","journal-title":"Toxicol. in Vitro"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110278_bb0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2020","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110278_bb0180","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ejh.13593","article-title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series","volume":"106","author":"Hansen","year":"2021","journal-title":"Eur. J. Haematol."},{"issue":"19","key":"10.1016\/j.ymgme.2026.110278_bb0185","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110278_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-031-59815-9_7","article-title":"Genetics of primary hemophagocytic lymphohistiocytosis","volume":"1448","author":"Karageorgos","year":"2024","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:31:02Z","timestamp":1794252662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1096719226005615"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110278","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110278"}}